Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2025-06-20 00:00:00 ET · period of report 2025-06-18 · accession 0001641172-25-015756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-20 | 2025-06-18 | IMMX | Rachman Ilya M | CEO, COB, Dir | P - Purchase | $2.30 | +2,178 | 1.14M | +0.2% | +$5,009 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-18 | P | A | 2,178 | $2.30 | 1,138,437 | D | — | — | (F1) Volume-weighted average price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |